Literature DB >> 29098221

The molecular mechanism of Nystatin action is dependent on the membrane biophysical properties and lipid composition.

A G Dos Santos1, J T Marquês, A C Carreira, I R Castro, A S Viana, M-P Mingeot-Leclercq, R F M de Almeida, L C Silva.   

Abstract

Nystatin (Nys) is a pore forming broad-spectrum and efficient antifungal drug with significant toxicity in mammalian organisms. In order to develop a non-toxic and more effective Nys formulation, its molecular mechanism of action at the cell membrane needs to be better understood. It is widely accepted that Nys activity and toxicity depend on the presence and type of membrane sterols. Taking advantage of multiple biophysical methodologies, we now show that the formation and stabilization of Nys aqueous pores, which are associated with Nys cytotoxicity, occur in the absence of membrane sterols. Our results suggest that the Nys mechanism of action is driven by the presence of highly ordered membrane domains capable of stabilizing the Nys oligomers. Moreover, Nys pore formation is accompanied by strong Nys-induced membrane reorganization that depends on membrane lipid composition and seems to underlie the Nys cytotoxic effect. Accordingly, in membranes enriched in a gel-phase forming phospholipid, Nys incorporates within the phospholipid-enriched gel domains, where it forms pores able to expand the gel domains. In contrast, in membranes enriched in gel domain forming sphingolipids, Nys-induced pore formation occurs through the destabilization of the gel phase. These results show that the Nys mechanism of action is complex and not only dependent on membrane sterols, and provide further insight into the molecular details governing Nys activity and toxicity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29098221     DOI: 10.1039/c7cp05353c

Source DB:  PubMed          Journal:  Phys Chem Chem Phys        ISSN: 1463-9076            Impact factor:   3.676


  7 in total

Review 1.  Comparison of Antibiotic Resistance Mechanisms in Antibiotic-Producing and Pathogenic Bacteria.

Authors:  Hiroshi Ogawara
Journal:  Molecules       Date:  2019-09-21       Impact factor: 4.411

2.  Effects of lipid membrane composition on the distribution of biocidal guanidine oligomer with solid supported lipid membranes.

Authors:  Yeonjeong Ha; Jung-Hwan Kwon
Journal:  RSC Adv       Date:  2020-06-10       Impact factor: 4.036

3.  TOR complex 2-regulated protein kinase Ypk1 controls sterol distribution by inhibiting StARkin domain-containing proteins located at plasma membrane-endoplasmic reticulum contact sites.

Authors:  Françoise M Roelants; Neha Chauhan; Alexander Muir; Jameson C Davis; Anant K Menon; Timothy P Levine; Jeremy Thorner
Journal:  Mol Biol Cell       Date:  2018-06-21       Impact factor: 4.138

4.  Self-assembled nanostructures of L-ascorbic acid alkyl esters support monomeric amphotericin B.

Authors:  Natalia E Nocelli; Yenisleidy de Las Mercedes Zulueta Díaz; Marine Millot; María Luz Colazo; Raquel V Vico; Maria Laura Fanani
Journal:  Heliyon       Date:  2021-01-28

Review 5.  Polyene Antibiotics Physical Chemistry and Their Effect on Lipid Membranes; Impacting Biological Processes and Medical Applications.

Authors:  Tammy Haro-Reyes; Lucero Díaz-Peralta; Arturo Galván-Hernández; Anahi Rodríguez-López; Lourdes Rodríguez-Fragoso; Iván Ortega-Blake
Journal:  Membranes (Basel)       Date:  2022-06-30

6.  Yeast Sphingolipid-Enriched Domains and Membrane Compartments in the Absence of Mannosyldiinositolphosphorylceramide.

Authors:  Andreia Bento-Oliveira; Filipa C Santos; Joaquim Trigo Marquês; Pedro M R Paulo; Thomas Korte; Andreas Herrmann; H Susana Marinho; Rodrigo F M de Almeida
Journal:  Biomolecules       Date:  2020-06-06

7.  The Verticillium dahliae Sho1-MAPK pathway regulates melanin biosynthesis and is required for cotton infection.

Authors:  Jun-Jiao Li; Lei Zhou; Chun-Mei Yin; Dan-Dan Zhang; Steven J Klosterman; Bao-Li Wang; Jian Song; Dan Wang; Xiao-Ping Hu; Krishna V Subbarao; Jie-Yin Chen; Xiao-Feng Dai
Journal:  Environ Microbiol       Date:  2019-11-24       Impact factor: 5.491

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.